Search

Your search keyword '"Rancati, Tiziana"' showing total 375 results
Start Over Author "Rancati, Tiziana" Publication Type Academic Journals
375 results on '"Rancati, Tiziana"'

1. Optimising inter-patient image registration for image-based data mining in breast radiotherapy

Author

Jaikuna, Tanwiwat, Wilson, Fiona, Azria, David, Chang-Claude, Jenny, De Santis, Maria Carmen, Gutiérrez-Enríquez, Sara, van Herk, Marcel, Hoskin, Peter, Kotzki, Lea, Lambrecht, Maarten, Lingard, Zoe, Seibold, Petra, Seoane, Alejandro, Sperk, Elena, Paul Symonds, R, Talbot, Christopher J., Rancati, Tiziana, Rattay, Tim, Reyes, Victoria, Rosenstein, Barry S., de Ruysscher, Dirk, Vega, Ana, Veldeman, Liv, Webb, Adam, West, Catharine ML, Aznar, Marianne C, and Vasquez Osorio, Eliana

Published
2024
Full Text
View/download PDF

2. Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients

Author

Iacovacci, Jacopo, Serafini, Mara Serena, Avuzzi, Barbara, Badenchini, Fabio, Cicchetti, Alessandro, Devecchi, Andrea, Dispinzieri, Michela, Doldi, Valentina, Giandini, Tommaso, Gioscio, Eliana, Mancinelli, Elisa, Noris Chiorda, Barbara, Orlandi, Ester, Palorini, Federica, Possenti, Luca, Reis Ferreira, Miguel, Villa, Sergio, Zaffaroni, Nadia, De Cecco, Loris, Valdagni, Riccardo, and Rancati, Tiziana

Published
2024
Full Text
View/download PDF

4. Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

Author

Beckmann, Kerri R, Bangma, Chris H, Helleman, Jozien, Bjartell, Anders, Carroll, Peter R, Morgan, Todd, Nieboer, Daan, Santaolalla, Aida, Trock, Bruce J, Valdagni, Riccardo, Roobol, Monique J, Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Logothetis, Christopher, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline, Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Robert, Grégoire, Semjonow, Axel, Rannikko, Antti, Perry, Antoinette, Hugosson, Jonas, Rubio‐Briones, Jose, Hefermehl, Lukas, Shiong, Lee Lui, Frydenberg, Mark, Stricker, Phillip, Sugimoto, Mikio, Chung, Byung Ha, van der Kwast, Theo, van der Linden, Wim, Hulsen, Tim, Ruwe, Boris, van Hooft, Peter, Steyerberg, Ewout, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Park, Lauren, Ferrante, Stephanie, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Stavrinides, Vasilis, Kimberly‐Duffell, Jenna, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Lin, Catherine Han, Cusick, Thomas, Hirama, Hiromi, Lee, Kwang Suk, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Kouspou, Michelle, and Paich, Kellie

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Urologic Diseases, Aging, Prevention, Cancer, Prostate Cancer, Clinical Research, Biopsy, Disease Progression, Humans, Male, Neoplasm Grading, Prostate, Prostate-Specific Antigen, Prostatic Neoplasms, Watchful Waiting, active surveillance, biopsy schedule, prostate cancer, treatment, upgrading, Global Action Plan Active Surveillance Prostate Cancer [G.A.P.3] Consortium, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis
Abstract

BackgroundThe optimal interval for repeat biopsy during active surveillance (AS) for prostate cancer is yet to be defined. This study examined whether risk of upgrading (to grade group ≥ 2) or risk of converting to treatment varied according to intensity of repeat biopsy using data from the GAP3 consortium's global AS database.Materials and methodsIntensity of surveillance biopsy schedules was categorized according to centers' protocols: (a) Prostate Cancer Research International Active Surveillance project (PRIAS) protocols with biopsies at years 1, 4, and 7 (10 centers; 7532 men); (b) biennial biopsies, that is, every other year (8 centers; 4365 men); and (c) annual biopsy schedules (4 centers; 1602 men). Multivariable Cox regression was used to compare outcomes according to biopsy intensity.ResultsOut of the 13,508 eligible participants, 56% were managed according to PRIAS protocols (biopsies at years 1, 4, and 7), 32% via biennial biopsy, and 12% via annual biopsy. After adjusting for baseline characteristics, risk of converting to treatment was greater for those on annual compared with PRIAS biopsy schedules (hazard ratio [HR] = 1.66; 95% confidence interval [CI] = 1.51-1.83; p

Published
2022

7. Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer

Author

Pavarini, Maddalena, Alborghetti, Lisa, Aimonetto, Stefania, Maggio, Angelo, Landoni, Valeria, Ferrari, Paolo, Bianculli, Antonella, Petrucci, Edoardo, Cicchetti, Alessandro, Farina, Bruno, Ubeira-Gabellini, Maria Giulia, Salmoiraghi, Paolo, Moretti, Eugenia, Avuzzi, Barbara, Giandini, Tommaso, Munoz, Fernando, Magli, Alessandro, Sanguineti, Giuseppe, Magdalena Waskiewicz, Justyna, Rago, Luciana, Cante, Domenico, Girelli, Giuseppe, Vavassori, Vittorio, Di Muzio, Nadia Gisella, Rancati, Tiziana, Cozzarini, Cesare, and Fiorino, Claudio

Published
2024
Full Text
View/download PDF

12. Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation

Author

Sanguineti, Giuseppe, Pavarini, Maddalena, Munoz, Fernando, Magli, Alessandro, Cante, Domenico, Garibaldi, Elisabetta, Gebbia, Andrea, Noris Chiorda, Barbara, Girelli, Giuseppe, Villa, Elisa, Faiella, Adriana, Magdalena Waskiewicz, Justyna, Avuzzi, Barbara, Pastorino, Alice, Moretti, Eugenia, Rago, Luciana, Statuto, Teodora, Gatti, Marco, Rancati, Tiziana, Valdagni, Riccardo, Luigi Vavassori, Vittorio, Gisella Di Muzio, Nadia, Fiorino, Claudio, and Cozzarini, Cesare

Published
2024
Full Text
View/download PDF

13. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

Author

Olivier, Jonathan, Li, Weiyu, Nieboer, Daan, Helleman, Jozien, Roobol, Monique, Gnanapragasam, Vincent, Frydenberg, Mark, Sugimoto, Mikio, Carroll, Peter, Morgan, Todd M, Valdagni, Riccardo, Rubio-Briones, Jose, Robert, Grégoire, Stricker, Phillip, Hayen, Andrew, Schoots, Ivo, Haider, Masoom, Moore, Caroline M, Denton, Brian, Villers, Arnauld, Trock, Bruce, Ehdaie, Behfar, Filson, Christopher, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Semjonow, Axel, Rannikko, Antti, Perry, Antoinette, Hugosson, Jonas, Bjartell, Anders, Hefermehl, Lukas, Shiong, Lee Lui, Chung, Byung Ha, van der Kwast, Theo, Hulsen, Tim, van der Linden, Wim, Ruwe, Boris, van Hooft, Peter, Steyerberg, Ewout, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Park, Lauren, Ferrante, Stephanie, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Stavrinides, Vasilis, Kimberly-Duffell, Jenna, Santaolalla, Aida, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Lin, Catherine Han, Cusick, Thomas, Hirama, Hiromi, Lee, Kwang Suk, Jenster, Guido, Auvinen, Anssi, van Bochove, Kees, Kouspou, Michelle, and Paich, Kellie

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Prevention, Clinical Research, Biomedical Imaging, Clinical Trials and Supportive Activities, Aging, Cancer, Urologic Diseases, Prostate Cancer, Detection, screening and diagnosis, 4.2 Evaluation of markers and technologies, Magnetic resonance imaging, Prostate cancer, Active surveillance, Discontinuation, Worldwide, Nomogram, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 Consortium, Urology & Nephrology, Clinical sciences
Abstract

BackgroundThe inclusion criterion for active surveillance (AS) is low- or intermediate-risk prostate cancer. The predictive value of the presence of a suspicious lesion at magnetic resonance imaging (MRI) at the time of inclusion is insufficiently known.ObjectiveTo evaluate the percentage of patients needing active treatment stratified by the presence or absence of a suspicious lesion at baseline MRI.Design setting and participantsA retrospective analysis of the data from the multicentric AS GAP3 Consortium database was conducted. The inclusion criteria were men with grade group (GG) 1 or GG 2 prostate cancer combined with prostate-specific antigen

Published
2022

14. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Author

Jaikuna, Tanwiwat, Osorio, Eliana Vasquez, Azria, David, Chang-Claude, Jenny, De Santis, Maria Carmen, Gutiérrez-Enríquez, Sara, van Herk, Marcel, Hoskin, Peter, Lambrecht, Maarten, Lingard, Zoe, Seibold, Petra, Seoane, Alejandro, Sperk, Elena, Symonds, R Paul, Talbot, Christopher J., Rancati, Tiziana, Rattay, Tim, Reyes, Victoria, Rosenstein, Barry S., de Ruysscher, Dirk, Vega, Ana, Veldeman, Liv, Webb, Adam, West, Catharine M.L., and Aznar, Marianne C.

Published
2023
Full Text
View/download PDF

17. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Author

Jandu, Harkeran K., Veal, Colin D., Fachal, Laura, Luccarini, Craig, Aguado-Barrera, Miguel E., Altabas, Manuel, Azria, David, Baten, Adinda, Bourgier, Celine, Bultijnck, Renée, Colciago, Riccardo R., Farcy-Jacquet, Marie-Pierre, Chang-Claude, Jenny, Choudhury, Ananya, Dunning, Alison, Elliott, Rebecca M., Green, Sheryl, Gutiérrez-Enríquez, Sara, Herskind, Carsten, Lambrecht, Maarten, Monten, Christel, Rancati, Tiziana, Reyes, Victoria, Rosenstein, Barry S., De Ruysscher, Dirk, Carmen De Santis, Maria, Seibold, Petra, Sperk, Elena, Veldwijk, Marlon, Paul Symonds, R., Stobart, Hilary, Taboada-Valladares, Begoña, Vega, Ana, Veldeman, Liv, Webb, Adam J., Weltens, Caroline, West, Catharine M., Rattay, Tim, and Talbot, Christopher J.

Published
2023
Full Text
View/download PDF

18. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients

Author

Cicchetti, Alessandro, Fiorino, Claudio, Ebert, Martin A., Iacovacci, Jacopo, Kennedy, Angel, Joseph, David J., Denham, James W., Vavassori, Vittorio, Fellin, Gianni, Cozzarini, Cesare, Esposti, Claudio Degli, Gabriele, Pietro, Munoz, Fernando, Avuzzi, Barbara, Valdagni, Riccardo, and Rancati, Tiziana

Published
2023
Full Text
View/download PDF

20. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

Author

Van Hemelrijck, Mieke, Ji, Xi, Helleman, Jozien, Roobol, Monique J, van der Linden, Wim, Nieboer, Daan, Bangma, Chris H, Frydenberg, Mark, Rannikko, Antti, Lee, Lui S, Gnanapragasam, Vincent J, Kattan, Mike W, Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M, Gnanapragasam, Vincent, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Shiong, Lee Lui, Kakehi, Yoshiyuki, Chung, Byung Ha, van der Kwast, Theo, Obbink, Henk, Hulsen, Tim, de Jonge, Cees, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Steyerberg, Ewout, Zhang, Liying, Santa Olalla, Aida, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Tolosa, Emily, Kim, Tae-Kyung, Mamedov, Alexandre, La Pointe, Vincent, Crump, Trafford, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Lin, Catherine Han, Hirama, Hiromi, Lee, Kwang Suk, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Carter, Ballentine, Gledhill, Sam, Buzza, Mark, and Bruinsma, Sophie

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Prostate Cancer, Aging, Prevention, Urologic Diseases, Cancer, Good Health and Well Being, Aged, Asia, Australia, Biopsy, Cause of Death, Clinical Decision-Making, Databases, Factual, Disease Progression, Early Detection of Cancer, Europe, Humans, Kallikreins, Male, Middle Aged, North America, Patient Dropouts, Predictive Value of Tests, Prostate-Specific Antigen, Prostatic Neoplasms, Risk Assessment, Risk Factors, Time Factors, Watchful Waiting, Prostate cancer, Active surveillance, Discontinuation, Worldwide, Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium, Urology & Nephrology, Clinical sciences
Abstract

BackgroundCareful assessment of the reasons for discontinuation of active surveillance (AS) is required for men with prostate cancer (PCa).ObjectiveUsing Movember's Global Action Plan Prostate Cancer Active Surveillance initiative (GAP3) database, we report on reasons for AS discontinuation.Design, setting, and participantsWe compared data from 10296 men on AS from 21 centres across 12 countries.Outcome measurements and statistical analysisCumulative incidence methods were used to estimate the cumulative incidence rates of AS discontinuation.Results and limitationsDuring 5-yr follow-up, 27.5% (95% confidence interval [CI]: 26.4-28.6%) men showed signs of disease progression, 12.8% (95% CI: 12.0-13.6%) converted to active treatment without evidence of progression, 1.7% (95% CI: 1.5-2.0%) continued to watchful waiting, and 1.7% (95% CI: 1.4-2.1%) died from other causes. Of the 7049 men who remained on AS, 2339 had follow-up for >5yr, 4561 had follow-up for

Published
2019

21. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

Author

Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline, Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Robert, Grégoire, Semjonow, Axel, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Lui Shiong, Lee, Frydenberg, Mark, Stricker, Phillip, Sugimoto, Mikio, Ha Chung, Byung, van der Kwast, Theo, van der Linden, Wim, Hulsen, Tim, Ruwe, Boris, Peter van Hooft, Steyerberg, Ewout, Nieboer, Daan, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Park, Lauren, Ferrante, Stephanie, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Stavrinides, Vasilis, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Han Lin, Catherine, Cusick, Thomas, Hirama, Hiromi, Suk Lee, Kwang, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Kouspou, Michelle, Paich, Kellie, Helleman, Jozien, Remmers, Sebastiaan, Hyndman, Matthew E., Moore, Caroline M., Shiong Lee, Lui, Elhage, Oussama, Morgan, Todd M., Bangma, Chris H., and Roobol, Monique J.

Published
2022
Full Text
View/download PDF

22. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Author

Van der Weijst, Lotte, Aguado-Barrera, Miguel E., Azria, David, Berkovic, Patrick, Boisselier, Pierre, Briers, Erik, Bultijnck, Renée, Calvo-Crespo, Patricia, Chang-Claude, Jenny, Choudhury, Ananya, Defraene, Gilles, Demontois, Sylvian, Dunning, Alison M., Elliott, Rebecca M., Ennis, Dawn, Faivre-Finn, Corinne, Franceschini, Marzia, Gutiérrez-Enríquez, Sara, Herskind, Carsten, Higginson, Daniel S., Kerns, Sarah L., Johnson, Kerstie, Mollà, Meritxell, Lambrecht, Maarten, Ramos, Mónica, Rancati, Tiziana, Rimner, Andreas, Rosenstein, Barry S., De Ruysscher, Dirk, Salem, Ahmed, Sangalli, Claudia, Seibold, Petra, Sosa-Fajardo, Paloma, Sperk, Elena, Stobart, Hilary, Summersgill, Holly, Surmont, Veerle, Symonds, Paul, Taboada-Lorenzo, Begoña, Talbot, Christopher J., Valdagni, Riccardo, Vega, Ana, Veldeman, Liv, Veldwijk, Marlon R., Ward, Tim, Webb, Adam, West, Catharine M.L., and Lievens, Yolande

Published
2022
Full Text
View/download PDF

23. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Author

Azria, David, Briers, Erik, Chang-Claude, Jenny, Choudhury, Ananya, Dunning, Alison, Elliott, Rebecca M, Gutiérrez-Enríquez, Sara, Rancati, Tiziana, Rattay, Tim, Rosenstein, Barry S., De Ruysscher, Dirk, Seibold, Petra, Sperk, Elena, Paul Symonds, R, Stobart, Hilary, Talbot, Christopher J., Vega, Ana, Veldeman, Liv, Ward, Tim, Webb, Adam, West, Catharine M., Kerns, Sarah L., Amidon Morlang, Ashley, Lee, Sharon M., Peterson, Derick R., Marples, Brian, Zhang, Hong, Bylund, Kevin, Rosenzweig, Doug, Hall, William, De Ruyck, Kim, Stock, Richard G., Gómez-Caamaño, Antonio, Sosa-Fajardo, Paloma, Taboada-Valladares, Begoña, Aguado-Barrera, Miguel E., Parker, Chris, Fonteyne, Valérie, Bultijnck, Renée, Symonds, R. Paul, Johnson, Kerstie, Lambrecht, Maarten, de Ruysscher, Dirk, Vanneste, Ben, Elliott, Rebecca M., Herskind, Carsten, Veldwijk, Marlon R., Avuzzi, Barbara, Valdagni, Riccardo, Farcy Jacquet, Marie-Pierre, West, Catharine, Janelsins, Michelle, Chen, Yuhchyau, Messing, Edward, and Morrow, Gary

Published
2022
Full Text
View/download PDF

24. Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis.

Author

Chander, Anjali, Iacovacci, Jacopo, Pellon, Aize, Kataria, Rhadika, Grigoriadis, Anita, Maher, John, Sears, Cynthia, Bachrach, Gilad, Urbano, Teresa Guerrero, Lei, Mary, Petkar, Imran, Kong, Anthony, Ng, Tony, Orlandi, Ester, Iacovelli, Nicola Alessandro, De Cecco, Loris, Serafini, Mara Serena, Moyes, David, Rancati, Tiziana, and Ferreira, Miguel Reis

Published
2024
Full Text
View/download PDF

25. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

Author

Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M, Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Robert, Grégoire, Semjonow, Axel, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Lui Shiong, Lee, Frydenberg, Mark, Stricker, Phillip, Sugimoto, Mikio, Ha Chung, Byung, van der Kwast, Theo, Hulsen, Tim, van der Linden, Wim, Ruwe, Boris, van Hooft, Peter, Steyerberg, Ewout, Nieboer, Daan, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Park, Lauren, Ferrante, Stephanie, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Stavrinides, Vasilis, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Han Lin, Catherine, Cusick, Thomas, Hirama, Hiromi, Suk Lee, Kwang, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Kouspou, Michelle, Paich, Kellie, Helleman, Jozien, Li, Weiyu, Morgan, Todd M., Schoots, Ivo, and Moore, Caroline M.

Published
2022
Full Text
View/download PDF

27. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

Author

Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline, Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Robert, Grégoire, Semjonow, Axel, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Lui Shiong, Lee, Frydenberg, Mark, Stricker, Phillip, Sugimoto, Mikio, Ha Chung, Byung, van der Kwast, Theo, van der Linden, Wim, Hulsen, Tim, Ruwe, Boris, van Hooft, Peter, Steyerberg, Ewout, Nieboer, Daan, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Park, Lauren, Ferrante, Stephanie, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Stavrinides, Vasilis, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Han Lin, Catherine, Cusick, Thomas, Hirama, Hiromi, Suk Lee, Kwang, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Kouspou, Michelle, Paich, Kellie, Helleman, Jozien, Shiong Lee, Lui, and Elhage, Oussama

Published
2021
Full Text
View/download PDF

31. 1984: Cox-based prediction model of grade 5 bleeding after SBRT of ultra-centrally located lung tumors.

Author

Karlsson, Kristin, Rancati, Tiziana, Lindberg, Sara, Grozman, Vitali, Hoffmann, Lone, Khalil, Azza, Knap, Marianne Marquard, Nielsen, Tine Bjørn, Jeppesen, Stefan Starup, Kristiansen, Charlotte, Ramberg, Christina, Rogg, Lotte Victoria, Drugge, Ninni, Nyman, Jan, Josipovic, Mirjana, Persson, Gitte Fredberg, Olofsson, Jörgen, Bergström, Per, Rosenbrand, Hans-Olov, and Lödén, Britta

Subjects
*LUNG tumors, *PREDICTION models, *HEMORRHAGE
Published
2024
Full Text
View/download PDF

33. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative

Author

Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M., Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Shiong, Lee Lui, Frydenberg, Mark, Kakehi, Yoshiyuki, Chung, Byung Ha, van der Kwast, Theo, Obbink, Henk, van der Linden, Wim, Hulsen, Tim, Jonge, Cees de, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Steyerberg, Ewout, Nieboer, Daan, Zhang, Liying, Beckmann, Kerri, Denton, Brian, Hayen, Andrew, Boutros, Paul, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Tolosa, Emily, Kim, Tae-Kyung, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jonathan, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Lin, Catherine Han, Hirama, Hiromi, Lee, Kwang Suk, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Carter, Ballentine, Gledhill, Sam, Buzza, Mark, Bruinsma, Sophie, Helleman, Jozien, Kalapara, Arveen A., Verbeek, Jan F.M., Lee, Lui Shiong, Bangma, Chris H., Steyerberg, Ewout W., Harkin, Tim, and Roobol, Monique J.

Published
2020
Full Text
View/download PDF

35. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Author

Lievens, Yolande, van Eijkeren, Marc, Vandecasteele, Katrien, Elhamin, Elhaseen, Ost, Piet, Fonteyne, Valérie, Swimberghe, Martijn, Deseyne, Pieter, De Neve, Wilfried, Duprez, Fréderic, Mareel, Marcus, Monten, Chris, Van Greveling, Annick, Vercauteren, Tom, Paelinck, Leen, Defraene, Gilles, Aerts, Rita, Arredouani, Soumia, Lambrecht, Maarten, Vanneste, Ben, Draghici, Roxana, Giordano, Frank, Herskind, Carsten, Veldwijk, Marlon, Helmbold, Irmgard, Giesche, Ulrich, Stegmaier, Petra, Weiß, Christian, Blaschke, Thomas, Neu, Burkhard, Lozza, Laura, Avuzzi, Barbara, Morlino, Sara, Sangalli, Claudia, Franceschini, Marzia, Rodriguez-Lage, Belina, Fernández-Tajes, Juan, Fuentes-Rios, Olivia, Domínguez-Rios, Isabel, Fajardo-Paneque, Irene, Sosa-Fajardo, Paloma, Torrado-Moya, Laura, Ramos-Albiac, Mónica, Giraldo, Alexandra, Altabas, Manolo, Piqué-Leiva, Bibiana, García-Relancio, David, Seoane-Ramallo, Alejandro, Lavers, Samuel, Wright, Simon, Dobbelaere, Hannah, Appleton, Donna, Kaushik, Monika, Kenny, Frances, Khout, Hazem, Krupa, Jaroslaw, Lambert, Kelly V., Pilgrim, Simon, Shokuhi, Sheila, Valassiadou, Kalliope, Aznar-Garcia, Luis, Boiangui, Ion, Kancherla, Kiran, Kent, Christopher, Sampson, Kufre, Osman, Ahmed, Sridhar, Thiagarajan, Vasanthan, Subramaniam, Faivre-Finn, Corinne, Harrop, Victoria, Keni, Manjusha, Foweraker, Karen, Pascoe, Abigail, Esler, Claire, Stock, Richard, Green, Sheryl, Golchin, Ava, Li, William, Seibold, Petra, Webb, Adam, Aguado-Barrera, Miguel E., Azria, David, Bourgier, Celine, Brengues, Muriel, Briers, Erik, Bultijnck, Renée, Calvo-Crespo, Patricia, Carballo, Ana, Choudhury, Ananya, Cicchetti, Alessandro, Claßen, Johannes, Delmastro, Elena, Dunning, Alison M., Elliott, Rebecca M., Fachal, Laura, Farcy-Jacquet, Marie-Pierre, Gabriele, Pietro, Garibaldi, Elisabetta, Gómez-Caamaño, Antonio, Gutiérrez-Enríquez, Sara, Higginson, Daniel S., Johnson, Kerstie, Lobato-Busto, Ramón, Mollà, Meritxell, Müller, Anusha, Payne, Debbie, Peleteiro, Paula, Post, Giselle, Rancati, Tiziana, Rattay, Tim, Reyes, Victoria, Rosenstein, Barry S., De Ruysscher, Dirk, De Santis, Maria Carmen, Schäfer, Jörg, Schnabel, Thomas, Sperk, Elena, Symonds, R. Paul, Stobart, Hilary, Taboada-Valladares, Begoña, Talbot, Christopher J., Valdagni, Riccardo, Vega, Ana, Veldeman, Liv, Ward, Tim, Weißenberger, Christian, West, Catharine M.L., and Chang-Claude, Jenny

Published
2019
Full Text
View/download PDF

37. Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients

Author

Azria, David, Brookes, Anthony, Burr, Tom, Chang-Claude, Jenny, Davidson, Susan, De Ruysscher, Dirk, Dunning, Alison, Elliott, Rebecca, Gutiérrez Enríquez, Sara, Lambin, Philippe, Rancati, Tiziana, Rosenstein, Barry, Seibold, Petra, Symonds, R. Paul, Talbot, Chris, Thierens, Hubert, Valdagni, Riccardo, Vega, Ana, Veldeman, Liv, Wenz, Frederik, Yuille, Martin, West, Catharine, Johnson, K., Chang-Claude, J., Critchley, A.-M., Kyriacou, C., Lavers, S., Rattay, T., Seibold, P., Webb, A., West, C., Symonds, R.P., and Talbot, C.J.

Published
2019
Full Text
View/download PDF

38. Development of a Ready-to-Use Graphical Tool Based on Artificial Neural Network Classification: Application for the Prediction of Late Fecal Incontinence After Prostate Cancer Radiation Therapy

Author

Carrara, Mauro, Massari, Eleonora, Cicchetti, Alessandro, Giandini, Tommaso, Avuzzi, Barbara, Palorini, Federica, Stucchi, Claudio, Fellin, Giovanni, Gabriele, Pietro, Vavassori, Vittorio, Degli Esposti, Claudio, Cozzarini, Cesare, Pignoli, Emanuele, Fiorino, Claudio, Rancati, Tiziana, and Valdagni, Riccardo

Published
2018
Full Text
View/download PDF

40. Comparing Performances of Predictive Models of Toxicity after Radiotherapy for Breast Cancer Using Different Machine Learning Approaches.

Author

Ubeira-Gabellini, Maria Giulia, Mori, Martina, Palazzo, Gabriele, Cicchetti, Alessandro, Mangili, Paola, Pavarini, Maddalena, Rancati, Tiziana, Fodor, Andrei, del Vecchio, Antonella, Di Muzio, Nadia Gisella, and Fiorino, Claudio

Subjects
PREDICTIVE tests, DATABASE management, DATA analysis, RECEIVER operating characteristic curves, RESEARCH funding, RADIATION injuries, BREAST tumors, LOGISTIC regression analysis, TREATMENT effectiveness, RADIATION dosimetry, DESCRIPTIVE statistics, STATISTICS, MACHINE learning
Abstract

Simple Summary: Studies comparing performances of machine learning (ML) methods in building predictive models of toxicity in RT are rare. Thanks to the availability of a large cohort (n = 1314) of breast cancer patients homogeneously treated with tangential fields, different ML approaches could be compared. This work shows how more complex models typically achieve higher performances. At the same time, for this test case, the importance is given mainly by a few variables, and toxicity can be predicted by simpler models with similar performances. The availability of more individually characterizing features (here partially missing) is expected to have a likely much higher impact than the choice of the best-performing ML/DL approach. Purpose. Different ML models were compared to predict toxicity in RT on a large cohort (n = 1314). Methods. The endpoint was RTOG G2/G3 acute toxicity, resulting in 204/1314 patients with the event. The dataset, including 25 clinical, anatomical, and dosimetric features, was split into 984 for training and 330 for internal tests. The dataset was standardized; features with a high p-value at univariate LR and with Spearman ρ > 0.8 were excluded; synthesized data of the minority were generated to compensate for class imbalance. Twelve ML methods were considered. Model optimization and sequential backward selection were run to choose the best models with a parsimonious feature number. Finally, feature importance was derived for every model. Results. The model's performance was compared on a training–test dataset over different metrics: the best performance model was LightGBM. Logistic regression with three variables (LR3) selected via bootstrapping showed performances similar to the best-performing models. The AUC of test data is slightly above 0.65 for the best models (highest value: 0.662 with LightGBM). Conclusions. No model performed the best for all metrics: more complex ML models had better performances; however, models with just three features showed performances comparable to the best models using many (n = 13–19) features. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT.

Author

Maggio, Angelo, Rancati, Tiziana, Gatti, Marco, Cante, Domenico, Avuzzi, Barbara, Bianconi, Cinzia, Badenchini, Fabio, Farina, Bruno, Ferrari, Paolo, Giandini, Tommaso, Girelli, Giuseppe, Landoni, Valeria, Magli, Alessandro, Moretti, Eugenia, Petrucci, Edoardo, Salmoiraghi, Paolo, Sanguineti, Giuseppe, Villa, Elisa, Waskiewicz, Justyna Magdalena, and Guarneri, Alessia

Subjects
*PROSTATE cancer patients, *INTENSITY modulated radiotherapy, *QUALITY of life, *PROSTATE cancer, *APPETITE loss, *PHYSICAL mobility
Abstract

Purpose: The purpose of this study is to study the evolution of quality of life (QoL) in the first 5 years following Intensity-modulated radiation therapy (IMRT) for prostate cancer (PCa) and to determine possible associations with clinical/treatment data. Material and methods: Patients were enrolled in a prospective multicentre observational trial in 2010-2014 and treated with conventional (74–80 Gy, 1.8–2 Gy/fr) or moderately hypofractionated IMRT (65–75.2 Gy, 2.2–2.7 Gy/fr). QoL was evaluated by means of EORTC QLQ-C30 at baseline, at radiation therapy (RT) end, and every 6 months up to 5 years after IMRT end. Fourteen QoL dimensions were investigated separately. The longitudinal evaluation of QoL was analysed by means of Analysis of variances (ANOVA) for multiple measures. Results: A total of 391 patients with complete sets of questionnaires across 5 years were available. The longitudinal analysis showed a trend toward the significant worsening of QoL at RT end for global health, physical and role functioning, fatigue, appetite loss, diarrhoea, and pain. QoL worsening was recovered within 6 months from RT end, with the only exception being physical functioning. Based on ANOVA, the most impaired time point was RT end. QoL dimension analysis at this time indicated that acute Grade ≥ 2 gastrointestinal (GI) toxicity significantly impacted global health, physical and role functioning, fatigue, appetite loss, diarrhoea, and pain. Acute Grade ≥ 2 genitourinary (GU) toxicity resulted in lower role functioning and higher pain. Prophylactic lymph-nodal irradiation (WPRT) resulted in significantly lower QoL for global health, fatigue, appetite loss, and diarrhoea; lower pain with the use of neoadjuvant/concomitant hormonal therapy; and lower fatigue with the use of an anti-androgen. Conclusions: In this prospective, longitudinal, observational study, high radiation IMRT doses delivered for PCa led to a temporary worsening of QoL, which tended to be completely resolved at six months. Such transient worsening was mostly associated with acute GI/GU toxicity, WPRT, and higher prescription doses. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

43. 2937: Dose deposition in sub-regions of breast relates to acute and persistent pain after radiotherapy

Author

Jaikuna, Tanwiwat, Wilson, Fiona, Azria, David, Chang-Claude, Jenny, De Santis, Maria Carmen, Enríquez, Sara Gutiérrez, van Herk, Marcel, Hoskin, Peter, Lambrecht, Maarten, Lingard, Zoe, Seibold, Petra, Sperk, Elena, Symonds, Paul R., Talbot, Christopher J., Rancati, Tiziana, Rattay, Tim, Reyes, Victoria, Rosenstein, Barry S., de Ruysscher, Dirk, Vega, Ana, Veldeman, Liv, Webb, Adam, West, Catharine M L, Vasquez-Osorio, Eliana, and Aznar, Marianne C.

Published
2024
Full Text
View/download PDF

44. 2516: NTCP model of acute toxicity after whole breast irradiation: training and extended validation

Author

Cicchetti, Alessandro, Vincenzi, Monica, Castriconi, Roberta, Mangili, Paola, Fodor, Andrei, Gabellini, Maria Giulia Ubeira, Chiara, Anna, Deantoni, Chiara, Midulla, Martina, Mori, Martina, Pasetti, Marcella, Palazzo, Gabriele, Tummineri, Roberta, Torrisi, Miriam, Rancati, Tiziana, Vecchio, Antonella del, Di Muzio, Nadia G, and Fiorino, Claudio

Published
2024
Full Text
View/download PDF

46. 2437: Clinical predictors of late lymphopenia in PCa patients undergoing radical or post-operative WPRT

Author

Magli, Alessandro, Pavarini, Maddalena, Alborghetti, Lisa, Avuzzi, Barbara, Cante, Domenico, Chiorda, Barbara Noris, De Rosa, Nicola, Faiella, Adriana, Garibaldi, Elisabetta, Girelli, Giuseppe, Gatti, Marco, Lazzari, Grazia, Waskiewicz, Justyna M., Munoz, Fernando, Pastorino, Alice, Piva, Cristina, Rago, Luciana, Sanguineti, Giuseppe, Statuto, Teodora, Villa, Elisa, Vavassori, Vittorio L., Rancati, Tiziana, Di Muzio, Nadia G, Fiorino, Claudio, and Cozzarini, Cesare

Published
2024
Full Text
View/download PDF

48. 2391: Longitudinal assessment of the impact of pelvic nodal radiotherapy on lymphopenia in PCa treatment

Author

Garibaldi, Elisabetta, Pavarini, Maddalena, Alborghetti, Lisa, Munoz, Fernando, Faiella, Adriana, Sanguineti, Giuseppe, Waskiewicz, Justyna M., Statuto, Teodora, Rago, Luciana, Lazzari, Grazia, Cante, Domenico, Piva, Cristina, Avuzzi, Barbara, Chiorda, Barbara Noris, Gatti, Marco, Rancati, Tiziana, Girelli, Giuseppe, Villa, Elisa, Vavassori, Vittorio L., Magli, Alessandro, Pastorino, Alice, De Rosa, Nicola, Di Muzio, Nadia G, Fiorino, Claudio, and Cozzarini, Cesare

Published
2024
Full Text
View/download PDF

50. 2287: Bone marrow dose-volume predictors of late lymphopenia after pelvic lymph node irradiation for PCa

Author

Pavarini, Maddalena, Alborghetti, Lisa, Aimonetto, Stefania, Maggio, Angelo, Landoni, Valeria, Ferrari, Paolo, Bianculli, Antonella, Petrucci, Edoardo, Cicchetti, Alessandro, Farina, Bruno, Salmoiraghi, Paolo, Moretti, Eugenia, Cazzulo, Elena, Carillo, Viviana, Munoz, Fernando, Magli, Alessandro, Sanguineti, Giuseppe, Waskiewicz, Justyna M., Rago, Luciana, Cante, Domenico, Girelli, Giuseppe, Rancati, Tiziana, Di Muzio, Nadia G, Cozzarini, Cesare, and Fiorino, Claudio

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results